| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |